--> 9:28am 12/17/04
Pfizer: Cardiovascular risk found in Celebrex study (PFE) By Ciara Linnane
NEW YORK (CBS.MW) -- Pfizer (PFE) said a study of its arthritis drug Celebrex for use in treating cancer has demonstrated an increased cardiovascular risk over placebo. In a statement, the company said it has suspended dosing in the study while it reviews the new data. A separate study of the long-term use of the drug in treating cancer revealed no increased risk of heart damage, it said."These clinical trial results are new," said the statement."The cardiovascular findings in one of the studies (APC) are unexpected and not consistent with the reported findings in the second study (PreSAP)." Celebrex is used to treat arthritis and pain. Pfizer shares were down 14 percent at $24.85 in premarket trade.

-->Bis 20:00 bohren sich die Ami-Börsen in den Boden. Und wenn der DAX schläft gehtes wieder ruck-zuck aufwärts

J

PS Das ist keine Anlage-Empfehlung sondern eine wilde Spekulation! [img][/img]